Daniel Kolansky, MD
Interventional Cardiology · Philadelphia, PANPI 1124054812
Payments from drug & device makers
Across 129 payments — averaging $225.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cathworks, Inc.$18K
- Madrigal Pharmaceuticals$6K
- Quidel Corporation$2K
- Medtronic$1K
- Abiomed$486
- Boston Scientific$197
- plus $688 from 13 others
Across 18 payments — averaging $4336.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ortho-clinical Diagnostics, Inc.$46K
- Quidel Corporation$32K
What the payments were for
- Consulting fees$8,59277%
- Food & beverage$2,53323%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cathworks, Inc. | 4 | $18,067 |
| Madrigal Pharmaceuticals | 23 | $6,467 |
| Quidel Corporation | 1 | $2,125 |
| Medtronic(2 entities) | 64 | $1,096 |
| Abiomed | 13 | $486 |
| Boston Scientific | 2 | $197 |
| Shockwave Medical, Inc | 4 | $160 |
| AstraZeneca | 1 | $106 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $97 |
| Edwards Lifesciences | 3 | $58 |
| Kestra Medical Technology Services, Inc. | 2 | $51 |
| Cardinal Health 200 LLC | 2 | $39 |
| Teleflex LLC | 2 | $38 |
| W. L. Gore & Associates, Inc. | 2 | $36 |
| Cordis US CORP. | 1 | $35 |
| Terumo Medical Corporation | 1 | $20 |
| Heartflow, Inc. | 1 | $18 |
| Stryker | 1 | $16 |
| Abbott | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,125 in reported general payments places this provider in the 70th percentile of 281 interventional cardiology providers in Pennsylvania.
See all interventional cardiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 12 | $18,506 |
| Ezetimibe | 55 | $1,975 |
| Rosuvastatin Calcium | 78 | $1,693 |
| Metoprolol Succinate | 43 | $514 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 17 | $505 |
| Atorvastatin Calcium | 43 | $418 |
| Carvedilol | 12 | $324 |
| Losartan Potassium | 43 | $283 |
| ClopidogrelClopidogrel Bisulfate | 24 | $267 |
| Valsartan | 13 | $172 |
| Amlodipine Besylate | 26 | $90 |
| Lisinopril | 12 | $76 |
| Hydrochlorothiazide | 17 | $56 |
| Amoxicillin | 16 | $24 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Philadelphia
- Howard HerrmannPhiladelphia$2.2M
- Jay GiriPhiladelphia$1M
- Sameer KhandharPhiladelphia$831K
- Jon GeorgePhiladelphia$728K
- Taisei KobayashiPhiladelphia$473K
- Sanjog KalraPhiladelphia$462K
- Ashwin NathanPhiladelphia$328K
- Gene ChangPhiladelphia$217K
- Sahil BankaPhiladelphia$148K
- Paul FiorilliPhiladelphia$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.